An African perspective on the genetic risk of chronic kidney disease: a systematic review

Abstract

BackgroundIndividuals of African ethnicity are disproportionately burdened with chronic kidney disease (CKD). However, despite the genetic link, genetic association studies of CKD in African populations are lacking.MethodsWe conducted a systematic review to critically evaluate the existing studies on CKD genetic risk inferred by polymorphism(s) amongst African populations in Africa. The study followed the HuGE handbook and PRISMA protocol. We included studies reporting on the association of polymorphism(s) with prevalent CKD, end-stage renaldisease (ESRD) or CKD-associated traits. Given the very few studies investigating the effects of the same single nucleotide polymorphisms (SNPs) on CKD risk, a narrative synthesis of the evidence was conducted.ResultsA total of 30 polymorphisms in 11 genes were investigated for their association with CKD, ESRD or related traits, all using the candidate-gene approach. Of all the included genes, MYH9, AT1R and MTHFR genes failed to predict CKD or related traits, while variants in the APOL1, apoE, eNOS, XPD, XRCC1, renalase, ADIPOQ, and CCR2 genes were associated with CKD or other related traits. Two SNPs (rs73885319, rs60910145) and haplotypes (G-A-G; G1; G2) of the apolipoprotein L1 (APOL1) gene were studied in more than one population group, with similar association with prevalent CKD observed. The remaining polymorphisms were investigated in single studies.ConclusionAccording to this systematic review, there is currently insufficient evidence of the specific polymorphisms that poses African populations at an increased risk of CKD. Large-scale genetic studies are warranted to better understand susceptibility polymorphisms, specific to African populations.Electronic supplementary materialThe online version of this article (10.1186/s12881-018-0702-x) contains supplementary material, which is available to authorized users.

The Use of ‘Omics for Diagnosing and Predicting Progression of Chronic Kidney Disease: A Scoping Review

“…In this regard, there are relatively few ‘omics studies that focus on hypertension in the context of CKD in African populations ( Alicic et al, 2017 ). There was a single study with individuals from West Africa, highlighting the lack of ‘omics research in continental Africans ( Chen et al, 2007 ), despite many studies documenting the well-established genetic link to CKD in African Americans ( APOL1- associated nephropathy) ( George et al, 2018 ).…”

Implications of institutional racism in the therapeutic itinerary of people with chronic renal failure

“…( 6 ) International studies also pointed out that the prevalence of CRF is four times higher in people of African ethnicity when compared to those of European ethnicity. ( 7 ) Something similar was found in the United States, where kidney disease predominantly affects African Americans. ( 8 ) The problem extends to kidney transplantation, a type of kidney replacement therapy that increases the quality of life of patients.…”

The Evolving Antibiotic Profile of Paediatric Urinary Tract Infections at a Tertiary Hospital in Cape Town

“…(29) Disease-associated variants and PRSs derived from these variants (identified by GWAS of European populations) frequently fail to replicate or perform well in non-European populations due to differences in allelic frequencies, linkage disequilibrium and haplotype structure, and confounding by environmental risk factors. (32) Genetic diversity between African ethnolinguistic groups is greater than the diversity between Europeans and Asians, which represent only a subset of African diversity. (33) A recent whole genome sequencing analysis of 426 individuals from 50 ethnolinguistic groups highlights the breadth of genetic diversity and complex patterns of admixture and genetic stratification in SSA, indicating that the development of pan-African PRSs for multifactorial complex diseases like CKD will be challenging.…”